As we race toward the as yet unimagined scientific and medicaltriumphs of the 21st century, no one is more hopeful about thejourney than I am. Nevertheless, moving ahead with cutting-edgeresearch must not mean leaving behind well-established internationalstandards for protecting human subjects in clinical trials.None of these principles is more important than the protectionof research subjects by informed consent based on full disclosureof potential risks and benefits.
I did not expect, or want, to complete my tenure as secretaryof health and human services by raising questions about thesafety of patients in clinical . . . [Full Text of this Article]
References
This article has been cited by other articles:
Fortun, P., West, J., Chalkley, L., Shonde, A., Hawkey, C.
(2008). Recall of informed consent information by healthy volunteers in clinical trials. QJM
101: 625-629
[Abstract][Full Text]
Swartling, U, Helgesson, G
(2008). Self-assessed understanding as a tool for evaluating consent: reflections on a longitudinal study. J. Med. Ethics
34: 557-562
[Abstract][Full Text]
Helgesson, G, Swartling, U
(2008). Views on data use, confidentiality and consent in a predictive screening involving children. J. Med. Ethics
34: 206-209
[Abstract][Full Text]
Gray, S. W., Hlubocky, F. J., Ratain, M. J., Daugherty, C. K.
(2007). Attitudes Toward Research Participation and Investigator Conflicts of Interest Among Advanced Cancer Patients Participating in Early Phase Clinical Trials. JCO
25: 3488-3494
[Abstract][Full Text]
Friedman, J. Y, Sugarman, J., Dhillon, J. K, DePuy, V., Pierre, C. K, Dinan, M. A, Allsbrook, J. S, Schulman, K. A, Weinfurt, K. P
(2007). Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants. Clin Trials
4: 272-278
[Abstract]
DeMets, D. L
(2006). Futility approaches to interim monitoring by data monitoring committees. Clin Trials
3: 522-529
[Abstract]
Campbell, E. G., Weissman, J. S., Vogeli, C., Clarridge, B. R., Abraham, M., Marder, J. E., Koski, G.
(2006). Financial Relationships between Institutional Review Board Members and Industry. NEJM
355: 2321-2329
[Abstract][Full Text]
Camilleri, M., Gamble, G. L., Kopecky, S. L., Wood, M. B., Hockema, M. L.
(2005). Principles and Process in the Development of the Mayo Clinic's Individual and Institutional Conflict of Interest Policy. Mayo Clin Proc.
80: 1340-1346
[Abstract]
Jacobs, A. K.
(2005). Rebuilding an Enduring Trust in Medicine: A Global Mandate: Presidential Address American Heart Association Scientific Sessions 2004. Circulation
111: 3494-3498
[Full Text]
Sugarman, J., Lavori, P. W., Boeger, M., Cain, C., Edson, R., Morrison, V., Yeh, S. S.
(2005). Evaluating the quality of informed consent. Clin Trials
2: 34-41
[Abstract]
DeMets, D. L, Fleming, T. R, Rockhold, F., Massie, B., Merchant, T., Meisel, A., Mishkin, B., Wittes, J., Stump, D., Califf, R.
(2004). Liability issues for data monitoring committee members. Clin Trials
1: 525-531
[Abstract]
Caulfield, T., Lemmens, T., Kinsella, D., McDonald, M.
(2004). Currents in Contemporary Ethics. J Law Med Ethics
32: 365-368
Hamvas, A., Madden, K. K., Nogee, L. M., Trusgnich, M. A., Wegner, D. J., Heins, H. B., Cole, F. S.
(2004). Informed Consent for Genetic Research. Arch Pediatr Adolesc Med
158: 551-555
[Abstract][Full Text]
Helft, P. R., Ratain, M. J., Epstein, R. A., Siegler, M.
(2004). Inside Information: Financial Conflicts of Interest for Research Subjects in Early Phase Clinical Trials. JNCI J Natl Cancer Inst
96: 656-661
[Abstract][Full Text]
DeMets, D., Califf, R., Dixon, D., Ellenberg, S., Fleming, T., Held, P., Julian, D., Kaplan, R., Levine, R., Neaton, J., Packer, M., Pocock, S., Rockhold, F., Seto, B., Siegel, J., Snapinn, S., Stump, D., Temple, R., Whitley, R.
(2004). Issues in regulatory guidelines for data monitoring committees. Clin Trials
1: 162-169
[Abstract]
Kotchen, T. A., Lindquist, T., Malik, K., Ehrenfeld, E.
(2004). NIH Peer Review of Grant Applications for Clinical Research. JAMA
291: 836-843
[Abstract][Full Text]
Winickoff, D. E., Winickoff, R. N.
(2003). The Charitable Trust as a Model for Genomic Biobanks. NEJM
349: 1180-1184
[Full Text]
Sellke, F. W.
(2003). Gene therapy in cardiac surgery: Is there a role?. J. Thorac. Cardiovasc. Surg.
125: 994-997
[Full Text]
Johns, M. M. E., Barnes, M., Florencio, P. S.
(2003). Restoring Balance to Industry-Academia Relationships in an Era of Institutional Financial Conflicts of Interest: Promoting Research While Maintaining Trust. JAMA
289: 741-746
[Abstract][Full Text]
Bekelman, J. E., Li, Y., Gross, C. P.
(2003). Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review. JAMA
289: 454-465
[Abstract][Full Text]
Ruel, M., Kelly, R. A., Sellke, F. W.
(2003). Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy. Card Surg Adult
2: 715-750
[Full Text]
Corbie-Smith, G., Thomas, S. B., St. George, D. M. M.
(2002). Distrust, Race, and Research. Arch Intern Med
162: 2458-2463
[Abstract][Full Text]
King, N. M. P.
(2002). RAC Oversight of Gene Transfer Research: A Model Worth Extending?. J Law Med Ethics
30: 381-389
DeMets, D. L., Califf, R. M.
(2002). Lessons Learned From Recent Cardiovascular Clinical Trials: Part II. Circulation
106: 880-886
[Full Text]
Levine, M. M, Campbell, J. D, Kotloff, K. L
(2002). Overview of vaccines and immunisation. Br Med Bull
62: 1-13
[Full Text]
Yank, V., Rennie, D.
(2002). Reporting of Informed Consent and Ethics Committee Approval in Clinical Trials. JAMA
287: 2835-2838
[Abstract][Full Text]
Steinbrook, R.
(2002). Improving Protection for Research Subjects. NEJM
346: 1425-1430
[Full Text]
Austin, M. A.
(2002). Ethical Issues in Human Genome Epidemiology: A Case Study Based on The Japanese American Family Study in Seattle, Washington. Am J Epidemiol
155: 585-592
[Abstract][Full Text]
Kalb, P. E., Koehler, K. G.
(2002). Legal Issues in Scientific Research. JAMA
287: 85-91
[Abstract][Full Text]
Puzas, J. E., O'Keefe, R. J., Lieberman, J. R.
(2002). The Orthopaedic Genome: What Does the Future Hold and Are We Ready?. JBJS
84: 133-141
[Full Text]
Annas, G. J.
(2001). Reforming Informed Consent to Genetic Research. JAMA
286: 2326-2328
[Full Text]
POBER, J. S., NEUHAUSER, C. S., POBER, J. M.
(2001). Obstacles facing translational research in academic medical centers. FASEB J.
15: 2303-2313
[Abstract][Full Text]
Abzug, M. J., Esterl, E. A.
(2001). Establishment of a Clinical Trials Office at a Children's Hospital. Pediatrics
108: 1129-1134
[Abstract][Full Text]
Crigger, N. J, Holcomb, L., Weiss, J.
(2001). Fundamentalism, Multiculturalism and Problems of Conducting Research with Populations in Developing Nations. Nurs Ethics
8: 459-468
[Abstract]
Cooper, J. D.
(2001). Paying the piper: the NETT strikes a sour note. Ann. Thorac. Surg.
72: 330-333
[Full Text]
Fitzgerald, G K., Delitto, A.
(2001). Considerations for Planning and Conducting Clinic-Based Research in Physical Therapy. ptjournal
81: 1446-1454
[Abstract][Full Text]
Levine, S. B., Stagno, S. J.
(2001). Informed Consent for Case Reports: The Ethical Dilemma of Right to Privacy Versus Pedagogical Freedom. J. Psychother. Pract. Res.
10: 193-201
[Abstract][Full Text]
Ashcroft, R., Pfeffer, N.
(2001). Ethics behind closed doors: do research ethics committees need secrecy?. BMJ
322: 1294-1296
[Full Text]
Kassirer, J. P.
(2001). Pseudoaccountability. ANN INTERN MED
134: 587-590
[Abstract][Full Text]
Martin, J. B., Kasper, D. L.
(2000). In Whose Best Interest? Breaching the Academic-Industrial Wall. NEJM
343: 1646-1649
[Full Text]
Korn, D.
(2000). Conflicts of Interest in Biomedical Research. JAMA
284: 2234-2237
[Full Text]